22-35745973-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_001349999.2(RBFOX2):c.1249G>A(p.Asp417Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000041 in 1,461,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001349999.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBFOX2 | NM_001349999.2 | c.1249G>A | p.Asp417Asn | missense_variant | Exon 13 of 14 | ENST00000695854.1 | NP_001336928.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBFOX2 | ENST00000695854.1 | c.1249G>A | p.Asp417Asn | missense_variant | Exon 13 of 14 | NM_001349999.2 | ENSP00000512219.1 | |||
RBFOX2 | ENST00000438146.7 | c.1261G>A | p.Asp421Asn | missense_variant | Exon 13 of 14 | 1 | ENSP00000413035.2 | |||
RBFOX2 | ENST00000449924.6 | c.1048G>A | p.Asp350Asn | missense_variant | Exon 12 of 13 | 1 | ENSP00000391670.2 | |||
RBFOX2 | ENST00000414461.6 | c.1008G>A | p.Pro336Pro | synonymous_variant | Exon 11 of 12 | 1 | ENSP00000407855.2 | |||
RBFOX2 | ENST00000695805.1 | n.*542G>A | non_coding_transcript_exon_variant | Exon 12 of 13 | ENSP00000512185.1 | |||||
RBFOX2 | ENST00000695807.1 | n.*4232G>A | non_coding_transcript_exon_variant | Exon 14 of 15 | ENSP00000512187.1 | |||||
RBFOX2 | ENST00000695805.1 | n.*542G>A | 3_prime_UTR_variant | Exon 12 of 13 | ENSP00000512185.1 | |||||
RBFOX2 | ENST00000695807.1 | n.*4232G>A | 3_prime_UTR_variant | Exon 14 of 15 | ENSP00000512187.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251302Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135832
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461676Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727160
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1261G>A (p.D421N) alteration is located in exon 13 (coding exon 13) of the RBFOX2 gene. This alteration results from a G to A substitution at nucleotide position 1261, causing the aspartic acid (D) at amino acid position 421 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 421 of the RBFOX2 protein (p.Asp421Asn). This variant is present in population databases (rs771797500, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with RBFOX2-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at